Health Catalyst Inc

Health Catalyst, Inc. engages in the provision of data and analytics technology and services to healthcare organizations. It operates through the Technology, and Professional Services segments. The Technology segment includes its data platform, analytics applications, and support services. The Professional Services segment combines analytics, implementation, strategic advisory, outsource, and improvement services to deliver expertise to its customers. The company was founded by Steven C. Barlow and Thomas D. Burton in 2008 and is headquartered in South Jordan, UT.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Health Catalyst Inc reports solid 2022 performance and eyes margin growth opportunities

Health Catalyst Inc delivered strong financial performance in 2022, with revenue growth, improved EBITDA, and a positive outlook for 2023. The company's focus on client relationships, tech-enabled services, and margin improvement positions it well for future success. Challenges such as long sales cycles and migration costs are being managed strategically to drive growth.

Health Catalyst beats Q1 revenue targets, eyes tech-enabled growth

Health Catalyst's Q1 2023 performance showed revenue growth and operational efficiency, with a focus on recurring revenue and client relationships.
While facing challenges in the health system market and revenue lumpiness, the company aims for growth through tech-enabled services and cost-saving strategies.
Opportunities lie in expanding into the ambulatory space, offering modular solutions, and investing in tech capabilities for long-term differentiation and client value.
Overall, Health Catalyst remains cautious about expansion, prioritizing being a differentiated long-term partner to effectively deliver for clients.

Health Catalyst beats Q2 expectations, eyes growth in managed services

Health Catalyst's Q2 performance exceeded expectations, with raised guidance for 2023.
Focus on tech-enabled managed services and long-term client relationships driving growth.
Challenges include longer sales cycles and improving gross margins in contracts.
Opportunities lie in margin improvement, summit impact on bookings, and clinic operations.

Health Catalyst Inc beats Q3 revenue, eyes strong Q4 bookings

Health Catalyst Inc (HCAT) exceeded revenue expectations in Q3 2023 and raised full-year guidance, with strong bookings performance.
The company is focusing on optimizing costs, anticipating a large bookings quarter in Q4 2023.
Recognized for team member engagement and client success stories, with a healthy cash position.
Anticipating growth opportunities in professional services and tech-enabled managed services contracts.

Health Catalyst exceeds Q4 revenue targets, eyes sustainable growth

Health Catalyst Inc's Q4 2023 earnings call highlighted strong financial performance, exceeding revenue and EBITDA guidance, with a focus on client growth and retention.
The company's strategic objectives include migrating clients to a next-gen data platform, balancing growth between tech and services, and driving profitability through operational efficiency.
While facing challenges in client migration and balancing growth, Health Catalyst is well-positioned to capitalize on opportunities like the next-gen platform rollout and cross-selling efforts.
Overall, Health Catalyst's performance, strengths, challenges, and opportunities indicate a strategic focus on sustainable growth, profitability, and enhancing client relationships.

Health Catalyst surpasses Q1 expectations, eyes tech-driven growth

Health Catalyst demonstrated financial resilience and client-centric approach in Q1 2024.
Strategic focus on technology and services to drive growth and avoid limitations.
Opportunities in adjacent markets and client engagement for sustained expansion.
Challenges include managing R&D expenses and potential disruptions from external factors.

Health Catalyst surpasses Q2 revenue targets, eyes growth opportunities

Health Catalyst's Q2 2024 performance exceeded expectations, showcasing strong revenue and margin metrics.
The company's strategic strengths lie in client recognition, acquisitions, platform migration progress, and growth outlook.
Challenges include client retention, revenue growth, margin optimization, and disciplined capital deployment.
Opportunities for Health Catalyst include leveraging financial strength, cross-selling, technology focus, and Ignite platform benefits.

Health Catalyst exceeds Q3 expectations, eyes growth through strategic initiatives

Health Catalyst Inc's Q3 2024 earnings call showcased strong financial performance, positive outlook, and strategic initiatives for growth.
The company's focus on client relationships, market demand, and acquisitions positions it well for future success and industry leadership.
While challenges like margin expansion and competition exist, Health Catalyst Inc's strengths and opportunities indicate a promising trajectory.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Health Catalyst, Inc. engages in the provision of data and analytics technology and services to healthcare organizations. It operates through the Technology and Professional Services segments. The Technology segment includes its data platform, analytics applications, and support services. The Professional Services segment combines analytics, implementation, strategic advisory, outsource, and improvement services to deliver expertise to its customers. The company was founded by Steven C. Barlow and Thomas D. Burton in 2008 and is headquartered in South Jordan, UT.

SALT LAKE CITY , May 9, 2023 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced a comprehensive, multi-year partnership with Sea Mar Community Health Centers ("Sea Mar"), a national leader in health and social services delivering high quality, integrated care for underserved communities. Sea Mar is a community-based organization committed to providing quality, comprehensive health, human, housing, educational and cultural services to diverse communities, specializing in service to Latinos in Washington state.

Sea Mar Community Health Centers and Health Catalyst Partner to Advance Healthcare in Underserved Communities

SALT LAKE CITY, May 09, 2023 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today reported financial results for the quarter ended March 31, 2023.

Health Catalyst Reports First Quarter 2023 Results

SALT LAKE CITY, April 25, 2023 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, will release its first quarter 2023 operating results on Tuesday, May 9, 2023, after market close. In conjunction, the company will host a conference call to review the results at 5 p.m. E.T. on the same day.

Health Catalyst to Announce First Quarter 2023 Operating Results and Host Conference Call on Tuesday, May 9, 2023

The consensus price target hints at a 30.4% upside potential for Health Catalyst (HCAT). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

Does Health Catalyst (HCAT) Have the Potential to Rally 30.43% as Wall Street Analysts Expect?

SALT LAKE CITY , April 4, 2023 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced a multi-year partnership with Contexture, the largest health information exchange (HIE) organization in the west. Contexture supports the flow of health information between thousands of physician practices, hospitals, long-term care facilities, labs, radiology centers, and other healthcare organizations.

Health Catalyst Solidifies Multi-Year Partnership with HIE Leader Contexture

DENVER & PHOENIX--(BUSINESS WIRE)--Contexture, the largest health information organization in the western U.S. serving Arizona and Colorado, today announced plans to transition to a unified technology platform for all its health information exchange (HIE) markets. Contexture will upgrade all HIE participants to the customized, end-to-end HIE solution powered by industry leading healthcare data and analytics technology provider Health Catalyst, Inc. (“Health Catalyst,” Nasdaq: HCAT).

Contexture Upgrades to Unified HIE Technology Platform for Improved Interoperability in Arizona and Colorado

Inspire Medical Systems Inc

Olink Holding AB

Zacks Medical Info Systems industry stocks like Inspire Medical Systems (INSP), Olink Holding (OLK) and Health Catalyst (HCAT) are expected to gain even as COVID-19 severity fades.

3 Medical Info Systems Stocks Countering Industry-wide Headwinds

Health Catalyst, Inc. has some strong market trends pushing it forward, and with a strong market presence I think the future seems very bright. What propels Health Catalyst's top-line growth is its unique product offering, an impressive record in mergers and acquisitions, and its potential to expand its customer base.

Health Catalyst: Riding A Steady Trend

SALT LAKE CITY , March 14, 2023 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced a partnership with GI Quality Improvement Consortium, Inc. (GIQuIC), a joint collaboration of the American College of Gastroenterology (ACG) and American Society of Gastrointestinal Endoscopy (ASGE). As noted in Health Catalyst's Q4 2022 earnings call announcement, GIQuiC which offers the only national gastroenterology-focused clinical registry, will utilize ARMUS by Health Catalyst's HYBRID Clinical Registry and Reporting solution to advance the extraction process, including a streamlined user experience, enhanced data capture process, and improved reporting.

Health Catalyst, GIQuIC Team Up to Power the Nation's Only Gastroenterology-Focused Clinical Registry

The data analytics specialist delivered results that weren't as bad as investors had feared.

Why Health Catalyst Stock Rallied Wednesday Morning

Health Catalyst, Inc. (NASDAQ:HCAT ) Q4 2022 Earnings Conference Call February 28, 2023 5:00 PM ET Company Participants Adam Brown – Senior Vice President-Finance and Investor Relations Dan Burton – Chief Executive Officer Bryan Hunt – Chief Financial Officer Conference Call Participants Stephanie Davis – SVB Securities Anne Samuel – JPMorgan Jared Haase – William Blair Jessica Tassan – Piper Sandler Daniel Grosslight – Citi Elizabeth Anderson – Evercore ISI Richard Close – Canaccord Genuity Thomas Kelliher – RBC Capital Markets David Larsen – BTIG Jack Wallace – Guggenheim Securities Operator Welcome to the Health Catalyst Fourth Quarter and Full Year 2022 Earnings Conference Call. At this time, all participants have been placed on a listen-only mode and the floor will be open for your questions following the presentation.

Health Catalyst, Inc. (HCAT) Q4 2022 Earnings Call Transcript

Health Catalyst (HCAT) delivered earnings and revenue surprises of 50% and 1.16%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

Health Catalyst (HCAT) Reports Q4 Loss, Tops Revenue Estimates

SALT LAKE CITY , Feb. 28, 2023 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced a multi-year contract expansion with partner INTEGRIS Health, Oklahoma's largest not-for-profit health system, to advance analytics capabilities across the INTEGRIS Health network, elevating its analytics program through specialized staffing and expanded technology access.   "At INTEGRIS Health, we are committed to our mission of partnering with people to live healthier lives.

INTEGRIS Health Partners with Health Catalyst to Further Data-Informed Healthcare Improvement

SALT LAKE CITY , Feb. 28, 2023 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced a comprehensive, multi-year strategic partnership with Deaconess Health System, a leading provider of healthcare services to 51 counties in three states; Indiana, Illinois, and Kentucky. Through the five-year partnership, Deaconess will utilize Health Catalyst's enterprise analytics and outcomes improvement expertise to transform clinical, operational, and financial domains for the health system.

Deaconess Health System Selects Health Catalyst's Data Platform to Drive Healthcare Transformation

SALT LAKE CITY , Feb. 28, 2023 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced an expansive, multi-year partnership with Bryan Health, an award-winning Nebraska-based health system. Bryan Health is renowned for providing both community and highly complex care at its medical centers in Eastern and central Nebraska.

Bryan Health Selects Health Catalyst to Accelerate Healthcare Transformation

SALT LAKE CITY , Feb. 28, 2023 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced that Matthew Kolb, Executive Vice President and Chief Operating Officer of Carle Health ("Carle"), has been appointed to serve as a member of Health Catalyst's board of directors ("Board"), effective July 1, 2023.  "Matt is deeply committed to Health Catalyst's and Carle Health's shared mission of data-informed healthcare improvement, and has been an extraordinary leader throughout his career in enabling massive improvements in the healthcare ecosystem.

Innovative Healthcare Executive and Carle Health COO Matthew Kolb Joins Health Catalyst Board of Directors; Carle Health Becomes Health Catalyst Shareholder

SOUTH JORDAN, Utah, Feb. 28, 2023 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today reported financial results for the quarter and year ended December 31, 2022.

Health Catalyst Reports Fourth Quarter and Year End 2022 Results

SALT LAKE CITY, Feb. 14, 2023 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, will release its fourth quarter and full year 2022 operating results on Tuesday, February 28, 2023, after market close. In conjunction, the company will host a conference call to review the results at 5 p.m. E.T. on the same day.

Health Catalyst to Announce Fourth Quarter and Full Year 2022 Operating Results and Host Conference Call on Tuesday, February 28, 2023

There are several underlying growth drivers further driving the adoption for HCAT solutions. HCAT differentiated product offering, strong M&A track record, and ability to further penetrate existing base of users are what drive top line growth.

HCA Healthcare: Expect Performance To Meet Long-Term Target Over Time

NextGen Healthcare Inc

10X Genomics

Zacks Medical Info Systems industry stocks like 10x Genomics (TXG), NextGen Healthcare (NXGN) and Health Catalyst (HCAT) are expected to gain as COVID-19 severity fades.

3 Medical Info Systems Stocks Braving Industry-wide Headwinds

SALT LAKE CITY , Jan. 6, 2023 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced that the leadership of the Church of Jesus Christ of Latter-Day Saints has called Paul Horstmeier, Health Catalyst's Chief Operating Officer, to serve for three years as the Mission President of the Puerto Rico San Juan Mission, beginning in late June 2023. As a result, Mr.

Health Catalyst Announces a New, External Leadership Assignment for Paul Horstmeier

Health Catalyst, Inc., after a 74% downside, spells opportunity, especially when ratings are all favorable. However, analysts at Evercore think differently and have downgraded Health Catalyst stock.

Health Catalyst: Tailwinds As Hospitals Use Tech To Offset Higher Costs

SALT LAKE CITY , Dec. 5, 2022 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced an expansive, multi-year contract with Carle Health (Carle)—an integrated health system based in Urbana, Illinois that includes five hospitals, multi-specialty physician group practices with more than 1,000 doctors and advanced practice providers, and Health Alliance Medical Plans—deepening its relationship with Health Catalyst to further advance Carle's innovative analytics capabilities system-wide. "Carle Health is excited to announce this novel partnership with Health Catalyst.

Carle Health Partners with Health Catalyst to Achieve Data-Informed Improvement

The consensus price target hints at a 61.5% upside potential for Health Catalyst (HCAT). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

Does Health Catalyst (HCAT) Have the Potential to Rally 61% as Wall Street Analysts Expect?

The average of price targets set by Wall Street analysts indicates a potential upside of 113% in Health Catalyst (HCAT). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

News for Health Catalyst Inc Stock (HCAT)